Background: Exogenous insulin therapy in Type 2 Diabetes Mellitus (T2DM) patients can trigger an immunological response in the form of Insulin Antibody (IA) formation. Theoretically, the presence of these antibodies potentially affects treatment efficacy and increases the daily insulin dose requirement due to a neutralizing effect. This study aimed to evaluate the correlation between Insulin An…